questionsmedicales.fr
Troubles dus à des produits chimiques
Effets secondaires indésirables des médicaments
Hypersensibilité médicamenteuse
Toxidermies
Toxidermies : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Toxidermies : Questions médicales les plus fréquentes",
"headline": "Toxidermies : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Toxidermies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Toxidermies"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité médicamenteuse",
"url": "https://questionsmedicales.fr/mesh/D004342",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité médicamenteuse",
"code": {
"@type": "MedicalCode",
"code": "D004342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pustulose exanthématique aigüe généralisée",
"alternateName": "Acute Generalized Exanthematous Pustulosis",
"url": "https://questionsmedicales.fr/mesh/D056150",
"about": {
"@type": "MedicalCondition",
"name": "Pustulose exanthématique aigüe généralisée",
"code": {
"@type": "MedicalCode",
"code": "D056150",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome d'hypersensibilité médicamenteuse",
"alternateName": "Drug Hypersensitivity Syndrome",
"url": "https://questionsmedicales.fr/mesh/D063926",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome d'hypersensibilité médicamenteuse",
"code": {
"@type": "MedicalCode",
"code": "D063926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.262"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Érythème noueux",
"alternateName": "Erythema Nodosum",
"url": "https://questionsmedicales.fr/mesh/D004893",
"about": {
"@type": "MedicalCondition",
"name": "Érythème noueux",
"code": {
"@type": "MedicalCode",
"code": "D004893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome mains-pieds",
"alternateName": "Hand-Foot Syndrome",
"url": "https://questionsmedicales.fr/mesh/D060831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome mains-pieds",
"code": {
"@type": "MedicalCode",
"code": "D060831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.587"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Nicolau",
"alternateName": "Nicolau Syndrome",
"url": "https://questionsmedicales.fr/mesh/D065148",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Nicolau",
"code": {
"@type": "MedicalCode",
"code": "D065148",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.693"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie sérique",
"alternateName": "Serum Sickness",
"url": "https://questionsmedicales.fr/mesh/D012713",
"about": {
"@type": "MedicalCondition",
"name": "Maladie sérique",
"code": {
"@type": "MedicalCode",
"code": "D012713",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Stevens-Johnson",
"alternateName": "Stevens-Johnson Syndrome",
"url": "https://questionsmedicales.fr/mesh/D013262",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Stevens-Johnson",
"code": {
"@type": "MedicalCode",
"code": "D013262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Toxidermies",
"alternateName": "Drug Eruptions",
"code": {
"@type": "MedicalCode",
"code": "D003875",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yu Sawada",
"url": "https://questionsmedicales.fr/author/Yu%20Sawada",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan."
}
},
{
"@type": "Person",
"name": "Natsuko Saito-Sasaki",
"url": "https://questionsmedicales.fr/author/Natsuko%20Saito-Sasaki",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan."
}
},
{
"@type": "Person",
"name": "Teresa Correia",
"url": "https://questionsmedicales.fr/author/Teresa%20Correia",
"affiliation": {
"@type": "Organization",
"name": "Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal."
}
},
{
"@type": "Person",
"name": "Paulo Filipe",
"url": "https://questionsmedicales.fr/author/Paulo%20Filipe",
"affiliation": {
"@type": "Organization",
"name": "Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal."
}
},
{
"@type": "Person",
"name": "Etsuko Okada",
"url": "https://questionsmedicales.fr/author/Etsuko%20Okada",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37403191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cup.14487"
}
},
{
"@type": "ScholarlyArticle",
"name": "Temporal shifts of the microbiome associated with antibiotic treatment of purpuric drug eruptions related to epidermal growth factor receptor inhibitors.",
"datePublished": "2022-10-19",
"url": "https://questionsmedicales.fr/article/36200415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jdv.18640"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID-19 messenger RNA vaccination.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37102209",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1346-8138.16808"
}
},
{
"@type": "ScholarlyArticle",
"name": "Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38750379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-024-08551-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pityriasis Rosea-Like Eruption following anti-fatigue traditional herbs: Aconitum carmichaelii Debx and Panax Ginseng suspected.",
"datePublished": "2024-06-29",
"url": "https://questionsmedicales.fr/article/38951791",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12906-024-04556-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles dus à des produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D064419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Effets secondaires indésirables des médicaments",
"item": "https://questionsmedicales.fr/mesh/D064420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité médicamenteuse",
"item": "https://questionsmedicales.fr/mesh/D004342"
},
{
"@type": "ListItem",
"position": 5,
"name": "Toxidermies",
"item": "https://questionsmedicales.fr/mesh/D003875"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Toxidermies - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Toxidermies",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Toxidermies",
"description": "Comment diagnostiquer une toxidermie ?\nQuels tests sont utilisés pour confirmer une toxidermie ?\nQuels signes cliniques indiquent une toxidermie ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on confondre une toxidermie avec d'autres affections ?",
"url": "https://questionsmedicales.fr/mesh/D003875?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Toxidermies",
"description": "Quels sont les symptômes courants d'une toxidermie ?\nLes symptômes varient-ils selon le médicament ?\nUne toxidermie peut-elle provoquer des symptômes systémiques ?\nLes éruptions cutanées sont-elles toujours présentes ?\nLes démangeaisons sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D003875?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Toxidermies",
"description": "Comment prévenir les toxidermies ?\nLes tests allergiques sont-ils utiles ?\nFaut-il informer les médecins de ses allergies ?\nLes patients doivent-ils lire les notices des médicaments ?\nLes médicaments en vente libre sont-ils sûrs ?",
"url": "https://questionsmedicales.fr/mesh/D003875?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Toxidermies",
"description": "Quel est le traitement principal d'une toxidermie ?\nDes antihistaminiques sont-ils recommandés ?\nLes corticostéroïdes sont-ils utilisés ?\nFaut-il consulter un dermatologue ?\nLes soins de la peau sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D003875?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Toxidermies",
"description": "Quelles complications peuvent survenir ?\nLes infections peuvent-elles être une complication ?\nUne hospitalisation est-elle parfois nécessaire ?\nLes complications peuvent-elles être évitées ?\nLes séquelles cutanées sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D003875?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Toxidermies",
"description": "Quels sont les facteurs de risque de toxidermie ?\nLes maladies chroniques influencent-elles le risque ?\nLes femmes sont-elles plus à risque ?\nL'utilisation de plusieurs médicaments augmente-t-elle le risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D003875?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une toxidermie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique médicamenteux du patient."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer une toxidermie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cutanés ou des biopsies peuvent être réalisés pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une toxidermie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et parfois des symptômes systémiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux sont-ils importants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'allergies médicamenteuses aident à établir le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on confondre une toxidermie avec d'autres affections ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres dermatites ou infections cutanées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une toxidermie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des éruptions cutanées, démangeaisons, et parfois de la fièvre."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le médicament ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction du type de médicament impliqué."
}
},
{
"@type": "Question",
"name": "Une toxidermie peut-elle provoquer des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fièvre, des douleurs articulaires ou des troubles respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles toujours présentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines toxidermies peuvent ne pas présenter d'éruptions cutanées visibles."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons sont un symptôme courant dans de nombreuses toxidermies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les toxidermies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les médicaments connus pour provoquer des réactions cutanées est essentiel."
}
},
{
"@type": "Question",
"name": "Les tests allergiques sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests allergiques peuvent aider à identifier les médicaments à éviter."
}
},
{
"@type": "Question",
"name": "Faut-il informer les médecins de ses allergies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, toujours informer les professionnels de santé de ses allergies médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils lire les notices des médicaments ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, lire les notices peut aider à identifier les risques d'éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les médicaments en vente libre sont-ils sûrs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains médicaments en vente libre peuvent aussi provoquer des toxidermies."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal d'une toxidermie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste principalement à arrêter le médicament responsable et à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Des antihistaminiques sont-ils recommandés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antihistaminiques peuvent aider à soulager les démangeaisons et l'inconfort."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des corticostéroïdes topiques ou systémiques peuvent être prescrits pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Faut-il consulter un dermatologue ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consultation dermatologique est souvent nécessaire pour un traitement approprié."
}
},
{
"@type": "Question",
"name": "Les soins de la peau sont-ils importants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins doux de la peau peuvent aider à apaiser les irritations cutanées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves comme le syndrome de Stevens-Johnson peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections secondaires peuvent survenir en raison de lésions cutanées."
}
},
{
"@type": "Question",
"name": "Une hospitalisation est-elle parfois nécessaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hospitalisation peut être nécessaire pour des cas graves de toxidermie."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié."
}
},
{
"@type": "Question",
"name": "Les séquelles cutanées sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles cutanées comme des cicatrices peuvent survenir après une toxidermie."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de toxidermie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, l'âge avancé et la polypharmacie augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent augmenter la susceptibilité aux toxidermies."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les femmes peuvent être plus susceptibles aux toxidermies."
}
},
{
"@type": "Question",
"name": "L'utilisation de plusieurs médicaments augmente-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la prise de plusieurs médicaments simultanément augmente le risque d'éruptions."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'allergies médicamenteuses peuvent augmenter le risque."
}
}
]
}
]
}
Fixed drug eruption (FDE) is an adverse drug reaction characterized by recurrent circumscribed lesions at the same location upon re-exposure to the culprit medication, resulting in distinct postinflam...
Epidermal growth factor receptor (EGFR) inhibitors are selective and effective treatments for cancers with relevant mutations. Purpuric drug eruptions are an uncommon but clinically significant dermat...
To characterize temporal changes in the skin and mucosal microbiomes before and after antibiotic treatment of EGFR inhibitor-related purpuric drug eruptions....
Twelve patients who experienced EGFR inhibitor-related purpuric drug eruptions were recruited from a dermato-oncology clinic in Taiwan from May 2017 to April 2018. Swabs were obtained from skin lesion...
The alpha diversity (represented by the Shannon index) of the skin microbiome increased significantly in the recovered phase of purpuric drug eruptions compared with that of the active phase. By contr...
The cutaneous microbiome of purpuric drug eruptions showed a significant increase in alpha diversity and a decrease in the relative abundance of Staphylococcus following antibiotic treatment. These fi...
Generalized bullous fixed drug eruption (GBFDE) is a rare type of life-threatening severe cutaneous adverse reaction that is considered a medical emergency because of its potential lethality. Currentl...
Cutaneous adverse reactions to epidermal growth factor receptor inhibitors (EGFRi) are some of the most common side effects that patients experience. However, cutaneous adverse reactions that cause dy...
We conducted a multicenter retrospective review at three academic institutions to identify patients with EDP induced by EGFRi from 2017 to 2023 and included sixteen patients in our study....
The median age of patients was 66 years old, with 63% female and 37% male (Table 1). The majority of our patients were Asian (88%). All patients had non-small cell lung cancer and most patients receiv...
Traditional herbs have a history of clinical use in anti-fatigue. However, several adverse effects of herbs have been identified. Pityriasis rosea-like eruption (PR-LE) is a rare cutaneous complicatio...
A 63-year-old woman presented at our emergency department with a disseminated dermatosis that developed after undergoing a cardiac catheterization procedure. Her past medical history included an end-s...
Drug reactions affecting the vulva are understudied and underreported, with some having the potential to cause serious morbidity through long term sequelae. We conducted a literature review to investi...
Drug patch test to identify cutaneous adverse drug reactions (CADRs) has been widely reported. Appropriate vehicles can improve the ability of drug delivery and significantly increase positive reactio...
The aim of this study was to evaluate the efficacy of drug patch tests using 0.9% saline vehicle in comparison with other traditional vehicles in CADRs....
All patients were patch tested with suspected drugs using 10-30% concentration of the commercialized form of drugs diluted in 0.9% saline, petrolatum, and water....
Of 100 patients with CADRs, 54 of those had at least one positive drug patch test. In terms of vehicles used, 43 patients had positive drug patch test with saline as compared to 35 with water (p = 0.4...
Appropriate vehicles are essential to obtain the positive drug patch test. Using saline as a vehicle can increase the positive reaction of drug patch test, particularly in lichenoid drug eruption. We ...
Cutaneous adverse drug reaction (CADR) is a common problem in clinical medication. This study aimed to investigate the correlation between clinical drug application and CADR occurrence as evidence for...
We analyzed the characteristics of CADRs of 858 patients admitted to Shandong Provincial Third Hospital from March 2007 to December 2018. The most significant drugs concerning the common skin symptoms...
A total of 266 drugs were involved in 858 cases of CADR. Among the ten most relevant medications, primarily antibiotics and herbal injections, and nutritional support drugs, potassium sodium dehydroan...
Drug-induced CADR symptoms are commonly associated with other ARDs, predominantly rashes and pruritus, and are often accompanied by some medical conditions, especially liver and kidney damage. Detaile...
Fixed drug eruptions (FDE) are typically associated with residual hyperpigmentation or non-pigmenting lesions. There is no distinctive histopathological feature; though, drug provocation tests (DPT) c...